BSI Closes €2.1M Funding Round for Development of Protein Biomarker Lung Cancer Test
July 23, 2010
BSI Closes €2.1M Funding Round for Development of Protein Biomarker Lung Cancer Test
The company will be using the funds to develop and test a prototype of the diagnostic, which it hopes to bring to market sometime in 2011, said a company official.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- BSI Merges with MBC to Secure Access to Nanoarray Technology and New Academic and Pharma Markets
September 17, 2010 / ProteoMonitor - BSI Partnering with Pharnext on $14.2M Initiative to Develop Biomarkers and Therapeutics for AD
November 19, 2010 / ProteoMonitor - Magnetic Biosensor Could Enable Simultaneous Monitoring of Thousands of Protein-Ligand Bindings
May 6, 2011 / ProteoMonitor - Proteomics Firms Net More than $8.75M in IRS Funds; Bulk of Awards Aimed at Diagnostics Work
November 5, 2010 / ProteoMonitor - SuppreMol to Use Protagen Biomarker Panel
August 2, 2011 / GenomeWeb Daily News